We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Dr. Rafael Simó receiving Eva Kohner Award.
Dr. Rafael Simó giving the lecture of admission as a member of the Royal Academy of Medicine of Catalonia.
Dr. Simó has also recently pronounced the lecture of admission as a new member of the Royal Academy of Medicine of Catalonia.
On June 2, Dr. Rafael Simó, head of the Endocrinology and Nutrition Service at Vall d'Hebron University Hospital and of the Diabetes and Metabolism research group at Vall d'Hebron Research Institute (VHIR), received in Coimbra (Portugal) the prestigious Eva Kohner Award at the congress organized by the Ocular Complications Study Group of the European Foundation for the Study of Diabetes. This award recognizes the trajectory in basic and clinical research in diabetic retinopathy and has been granted to world-renowned leaders in this field.
Diabetic retinopathy is the most common microvascular complication associated with diabetes, and the leading cause of preventable visual impairment and blindness in the working-age population worldwide. In recent years, Dr. Simó has led several lines of research to identify new therapeutic targets and strategies to prevent and treat the early stages of this disease based on neuroprotection.
As part of the event, Dr. Rafael Simó gave the lecture "Neurovascular Unit impairment in Diabetic Retinopathy: Clinical and Therapeutic implications" and previously explained his relationship with Dr. Eva Kohner and her influence on his research career.
On June 6, Dr. Rafael Simó also gave the lecture of admission as a member of the Royal Academy of Medicine of Catalonia (RAMC) after receiving the Joaquin Barraquer Award last January. Dr. Simó spoke about his contributions to the pathogenesis and discovery of new therapeutic targets in diabetic retinopathy.
Eva Kohner Award in diabetic retinopathy
The prize awarded by the Ocular Complications Study Group of the European Foundation for the Study of Diabetes is named in honor of the Hungarian ophthalmologist Eva Kohner (23 February 1929 – 24 September 2021). Born in Budapest in a wealthy Jewish family, Dr. Kohner survived the Nazi Holocaust and fled her country to London, where she first enrolled in nursing school and then studied medicine, graduating in 1959.
Her passion was the study of diabetic retinopathy, which was then an incurable cause of blindness. Dr. Kohner described the pathophysiology and natural history of the disease and pioneered photocoagulation as an effective treatment. She was also instrumental in the introduction of screening programs for diabetic retinopathy and founded the Ocular Complications Study Group of the European Society for the Study of Diabetes (EASD), which is the framework for the award of the prize that bears her name.
Among the long list of titles and honors awarded to her, the Order of the British Empire by Her Majesty the Queen in 1995 and the Arnall Patz Medal of the Macula Society in 2002 stand out. Fate led her to spend her last years almost blind, a real contradiction for someone who dedicated her life to saving the sight of others.
In recent years, Dr. Simó has led several lines of research to identify new therapeutic targets and strategies to prevent and treat the early stages of diabetic retinopathy.
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.